Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
McKinsey
Accenture
US Army
Federal Trade Commission
Cantor Fitzgerald
Healthtrust
Citi
Julphar

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022114

« Back to Dashboard
NDA 022114 describes ZINGO, which is a drug marketed by Powder Pharms and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug. Additional details are available on the ZINGO profile page.

The generic ingredient in ZINGO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for NDA: 022114

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:4
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 022114

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 022114

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL 022114 NDA Powder Pharmaceuticals Inc. 61388-001 61388-001-48 12 POUCH in 1 CARTON (61388-001-48) > 1 POWDER in 1 POUCH
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL 022114 NDA 7T Pharma LLC 70645-123 70645-123-26 12 POWDER in 1 CARTON (70645-123-26)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYSTEM;INTRADERMALStrength0.5MG
Approval Date:Aug 16, 2007TE:RLD:No
Patent:► SubscribePatent Expiration:Mar 17, 2017Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Oct 22, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO INTRADERMAL INJECTION SYSTEM IS A DRUG DELIVERY SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION
Patent:► SubscribePatent Expiration:Apr 27, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION

Expired Orange Book Patents for NDA: 022114

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
UBS
AstraZeneca
Deloitte
Dow
Argus Health
Cerilliant
Teva
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot